Small Cap Feast

Small Cap Feast – 13 May 2019

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 898

Total number of AIM Companies trading: 827*
* As at 03 May 2019

Set Menu NEX Growth:

Total number of NEX Growth Market Companies (Incl Susp): 89*

Total number of NEX Growth Market Companies trading: 87*
* As at 03 May 2019

Set Menu Standard List:

Total number of Standard List Companies (Incl Susp): 161*

Total number of Standard List Companies trading: 141*
* As at 03 May 2019

Dish of the Day:

No Joiners Today

Off the Menu:

No Leavers Today

Dish of the Day:

No Joiners Today

Off the Menu:

No Leavers Today

What’s Cooking in the IPO Kitchen?

Main Market (Premium)

Jewel UK Midco Limited, the parent company of The Watches of Switzerland Group Limited, is looking to join the premium segment of the main market. Offer TBC, expect TBC

Finablr plc— global platform which provides Cross-Border Payments and Consumer Solutions, Consumer Foreign Exchange Solutions and B2B and Payment Technology Solutions to consumers and businesses in the large and growing payments and foreign exchange market is looking to list on the Main Market plans to raise $200m, expected May 2019

Main Market (Standard)

IMC Exploration Group (NEX: IMCP), focused on acquiring and exploring prospecting licence areas which have high potential for natural resource, is looking to admit its shares to the standard list and will withdraw for the NEX Exchange. Expected 11 June 2019

AIM

Induction Healthcare Group plc—a healthcare technology company focused on streamlining the delivery of care by Healthcare Professionals looking to join AIM. Expected raise of £14.58m at 115p, market cap of £34.07m. Expected 22 May 2019.

SDX Energy plc—a North Africa focused oil and gas company, announces its intention to complete a Canadian plan of arrangement under section 192 of the Canada Business Corporations Act and will have shares de-listed from the TSX-V and admitted to trading on AIM. Expected 28 May 2019, anticipated market cap of £76m

Renold plc—a leading international supplier of industrial chains and related power transmission products, announced that it will cancel the listing of the Company from the premium segment and apply for admission on AIM. Expected 06 June 2019.

Alumasc Group plc, the premium building products, systems and solutions group, has announced its intention to move from the Premium Segment of the main market to AIM. Expected market cap of £33.4m. Expected 25 June 2019

NEX Exchange

Arbuthnot Banking Group plc, primarily involved in banking and financial services including commercial banking, private banking, wealth planning and investment management, is looking to joining the NEX Exchange Growth Market. Expected 17 May 2019

 

Breakfast Buffet

Jadestone Energy (JSE.L) 51.25p £231.6m

Jadestone Energy, an independent oil and gas production company focused on the Asia Pacific region, provided a further update on its infill drilling programme at the Stag oilfield.

Drilling operations on the Stag 49H infill well successfully concluded on May 6, 2019, and the completion has now been run.  The Ensco 107 drilling rig has moved off location and is now off-hire.

The well was completed with sand screens and swell packers which take a few days to expand and set.  The Company will also conduct hook-up and commissioning activities and then put the well on production.  Based on the well data there is no anticipated variance to the pre-drill expectations for this well, which is targeting approximately 1.2mmbbls of 2P oil reserves.

 

Hurricane Energy (HUR.L) 48.4p £931.8m

Hurricane Energy, the UK based oil and gas company focused on hydrocarbon resources in naturally fractured basement reservoirs, provided an operational update in relation to the Early Production System development of the Lancaster field.

On 11 May 2019 hydrocarbons were introduced into the Aoka Mizu FPSO’s process system. Introduction of hydrocarbons is the final stage of the FPSO’s commissioning and marks the commencement of the Lancaster EPS start-up phase. During this phase, each of the two production wells will be individually tested and shut-in for data gathering purposes. Cleaning and testing (pigging) of the flowlines for flow assurance purposes will also take place during these shut-ins. The start-up phase will conclude with simultaneous flow from both wells for 72 consecutive hours, after which a further announcement of ‘First Oil’ will be made.

 

Midwich (MIDW.L) 623p £496.8m

Midwich, a specialist audio visual distributor to the trade market with operations across the UK and Ireland, Continental Europe and Asia Pacific, will hold its AGM at 10am today.

At the meeting Andrew Herbert, Chairman, will make the following statement:

“The Group delivered a strong performance in 2018, achieving revenue and profit growth across all our businesses and regions. We remain committed to our established strategy of delivering strong organic growth, supplemented by targeted acquisitions, as well as building our expertise in a broader range of markets and products. Trading in the first four months of the year has been in line with the Board’s expectations and we look forward with confidence.”

 

Swallowfield (SWL.L) 190p £32.56m

Swallowfield, a market leader in the development, formulation and supply of personal care and beauty products, including its own portfolio of brands, announced that Franklin Berrebi, NED, has notified the Board of Directors of his intention to retire, with effect from 30 June 2019.

Following his resignation, the Board will comprise three executive and three NEDs and the Company will therefore not be seeking a replacement in the immediate future. Franklin’s committee responsibilities will be shared amongst the remaining Directors.

 

Sirius Real Estate (SRE.L) 63.7p £1,316m

Sirius Real Estate, the leading operator of branded business parks providing conventional space and flexible workspace in Germany, has completed the acquisition of Buxtehude Business Park south west of Hamburg, in Lower Saxony, for a total consideration of 8.7m including acquisition costs. The vendor is a well known, international spirits company. The acquisition, notarised in March 2019, has been funded from existing cash resources.

The business park, which provides 28,532 sqm of lettable space (90% warehouse/ production space; 6% offices; and, 4% of other space) on a plot of 35,425 sqm, is being acquired with full vacant possession.  Sirius will make use of its operating platform to re-let the site using a multi-tenant strategy with an anchor tenant surrounded by several smaller tenants with multiple different lease lengths.

Buxtehude, located 30 km southwest of Hamburg city centre, is part of the Hamburg Metropolitan Region. It is attached to the city’s S-Bahn rapid transit network and has easy access to the Autobahn network. Major companies operating in the town include Airbus, Unilever and Pioneer.

 

Wey Education (WEY.L) 7.25p £6.99m

Wey Education published its interim results for the six months to 28 Feb 2019 and reports on a number of important developments within the business.

Turnover up 54.7% at £2.70m (2018: £1.74m)

Continued strong growth in both Interhigh and Academy21, reflected in turnover and gross profit margins

Adjusted PBT on continuing operations of £124k (2018: £23k)

Loss after tax of £895k (2018: £153k) after exceptional items of £571k and £310k of losses from discontinued operations in London and overseas

Cash balances strong at over £4.96m (2018: £4.35m)

Wey now focuses on its two core brands, InterHigh and Academy21, and their clear market opportunities

Investment in academic leadership, AI and quality of educational provision

Further development of the IT platform to enable alignment and scalability of both brands

Accreditation of Teaching Online qualification, setting standards in education delivery

 

Polarean Imaging (POLX.L) 15.75p £15.9m

Polarean Imaging, the clinical stage medical-imaging technology company, announced an update regarding the Company’s Phase III Clinical Trials.

The Clinical Trials are progressing at Duke University and at the University of Virginia and aim to demonstrate non-inferiority of the Company’s drug-device combination, which uses hyperpolarised 129-Xenon gas MRI, against an approved comparator for the evaluation of pulmonary ventilation.

Enrolment for the Clinical Trials has now passed 80% (39 of 48 patients) in the lung transplant pathway and 50% (16 of 32 patients) in the lung resection pathway.

To improve the rate of enrolment for the lung resection pathway in order to align the pathway completion dates and because neither site should enroll more than 65% of patients in a pathway, the Company plans to add a third trial site.

Polarean’s Directors remain confident that the Company is on track to meet its current timetable for the regulatory submission of a New Drug Application with the US FDA. If approved by the FDA, commercial launch is expected to occur during H22020.

 

Angling Direct (ANG.L) 84p £53.31m

Angling Direct, the largest specialist fishing tackle and equipment retailer in the UK, announced its audited financial results for the twelve months ended 31 Jan 2019.

Group sales of £42m up by 39% (2018: £30.2m)

Online sales of £22.3m up by 30% (2018: £17.1m) with international sales up by 112%

Store sales of £19.7m up by 50% (2018: £13.2m) including like-for-like store growth of 6.2%

Gross profit of £13.8m up by 40% (2018: £9.9m) with gross margin increasing to 32.9%

Net cash equivalents at 31 Jan 2019 of £13.5m (2018: £0.8m)

Successfully completed a placing raising £20m.

Store network increased to 24 at the year-end (2018: 21)

Continued investment in online marketing including the opening of the German, French and Benelux websites

International sales up by 112% exporting to more than 48 countries

Introduction of the new Kardex stock control and picking system is delivering efficiencies in distribution and warehousing, whilst also future proofing capacity.

 

Strategic Minerals (SML.L) 1.6p £22.46m

Strategic Minerals, a producing mineral company actively developing projects prospective for battery materials, announced that it has executed final unconditionally binding documentation for the acquisition from New Age Exploration Limited (“NAE”) of 50% of Cornwall Resources Limited (“CRL”) the JV vehicle holding the Redmoor tin and tungsten project located in Cornwall, England.

Binding contracts now signed with an agreed settlement date of 30 May 2019.

Consideration of A$5m to be paid progressively as follows:

A$2m on settlement scheduled for 30 May 2019

A$1m on 29 Nov 2019

A$1m on Net Smelter Sales arising from Redmoor production reaching A$50m

A further A$1m on Net Smelter Sales arising from Redmoor production reaching A$100m.

NAE to hold a charge over the Company’s CRL shares until 29 Nov 2019 payment made.

 

MYCELX Technologies (MYX.L) 205p £39.71m

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for the Oil and Gas market and commercial industrial markets worldwide, announced its audited results for the year ended 31 Dec 2018.

Total revenue increased 96% to $27m (FY17: $13.8m)

Achieved EBITDA of $5.6m (FY17: $0.5m)

Gross profit increased by 88% to $14.1m (FY17: $7.5m)

Net profit of $3.1m (FY17: net loss of $1.2m)

Total operating expenses up 18% year on year as MYCELX invested in staff and resources to support the Company’s rapid growth trajectory

Saudi Arabia: Three contract extensions with current customer and Two new contracts with an existing customer and a new customer

First sale into LNG industry in Australia. Canada: System sale in onshore oil production market

 

Head Chef:

Derren Nathan
0203 764 2344
derren.nathan@hybridan.com

*A corporate client of Hybridan LLP

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.